Medline Patch
Product Images NDC 53329-192

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Medline (NDC 53329-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medline Industries, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Step 2 Label (53329 191)

Step 2 Label (53329 191)
This is a Drug Facts label for a nicotine transdermal patch system designed as a stop-smoking aid for individuals who smoke more than 10 cigarettes per day. The active ingredient and dosage information are not available. Warnings advise to consult a doctor before use and to keep the patches out of reach of children. The system comes with a user manual and a behavior support program. The patch is a 24-hour time-release and should be used after completing Step 1. The patches are supplied in child-resistant pouches and should not be used if the individual pouches are open or torn. Inactive ingredients are listed, and there is a section for questions or comments directed to one's healthcare provider. The text includes errors and is not fully understandable.*
FDA Label Image

Step 1 Label (53329 192)

FDA Label Image

Step 3 Label (53329 193)

Step 3 Label (53329 193)
This is a description of a smoking cessation aid in the form of a clear transdermal nicotine patch that delivers 7mg of nicotine over a 24 hour period. The patch is to be used after completing STEP 2 of the behavioral support program provided with the product. The package contains 14 patches and should not be used if the individual pouches are opened or torn. The purpose of the product is to assist with smoking cessation. There appears to be some errors in the text which may impact the accuracy of the information.*
FDA Label Image

Schedule (Patch Schedule)

Schedule (Patch Schedule)
This is a description of a prescription plan for using patches to quit smoking. The plan involves three phases: weeks 1 through 4, weeks 5 and 6, and weeks 7 and 8. During weeks 1 through 4, one 21 mg patch should be used per day. During weeks 5 and 6, one 14 mg patch should be used per day. Finally, during weeks 7 and 8, one 7 mg patch should be used per day.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.